🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel

Recruitingn/aAges 18 Years - 62 YearsAllTG Therapeutics, Inc.
NCT07577583 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Received at least 1 dose of azer-cel in TG-Azercel -101 study. 2. Signed informed consent form (ICF). 3. Willingness and ability to adhere to the study schedule and all other protocol requirements. Exclusion Citeria: 1\. No unique exclusion criteria apply to this study.
💊

What it tests

  • No Intervention
📍

Where

1 site
TG Therapeutics Investigational Trial Site
Morrisville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy